Vicarious Surgical (RBOT) files 8-K; $11.50 warrant exercise price

Vicarious Surgical, Inc. filed a Form 8-K reporting a material event that attaches an Investor Presentation as Exhibit 99.1 and includes the interactive cover page XBRL file.

Rhea-AI Filing Summary

Vicarious Surgical, Inc. filed a Form 8-K reporting a material event that attaches an Investor Presentation as Exhibit 99.1 and includes the interactive cover page XBRL file. The filing lists trading symbols for the company’s common stock and warrants on the New York Stock Exchange, including warrants to purchase one share of Class A common stock at an exercise price of $11.50 per share (symbol RBOT WS). The document is signed by Stephen From, Chief Executive Officer. The filing text supplied is brief and contains exhibit and header details without additional financial tables, transaction terms, or earnings information.

Positive

• Investor Presentation (Exhibit 99.1) is filed, improving disclosure access to investors
• Warrant exercise price is specified at $11.50, giving a clear contractual number

Negative

• Filing contains limited substantive content; no financial results, transaction details, or guidance provided
• No material terms beyond exhibit listing are disclosed that would change valuation or near-term outlook

Insights

Securities Filings Analyst

TL;DR: The 8-K primarily attaches an investor presentation and confirms warrant terms; no financial results disclosed.

The filing formally discloses an Investor Presentation (Exhibit 99.1) and an interactive XBRL cover page, which are common ways to provide updated investor materials to the market.

The document also lists the company’s trading symbols and specifies the warrant exercise price of $11.50, a concrete contractual detail investors can verify in market records; there are no earnings, balance-sheet changes, or transaction closings described here.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vicarious Surgical (RBOT) disclose in the Form 8-K?

The company attached an Investor Presentation (Exhibit 99.1) and included the interactive XBRL cover page; no financial results were disclosed.

What warrant terms are listed for RBOT in this filing?

The filing lists warrants to purchase one share of Class A common stock with an exercise price of $11.50 per share (symbol RBOT WS).

Who signed the Form 8-K for Vicarious Surgical (RBOT)?

The document is signed by Stephen From, Chief Executive Officer.

Does the 8-K include earnings, major transactions, or financial tables?

No. The supplied filing text contains exhibit and header details only and does not include earnings, transaction closings, or financial tables.

Where are the company and warrant securities listed?

Both the company common stock and the warrants are listed on the New York Stock Exchange according to the filing text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/23/2025 - 05:06 PM Learn about SEC filing dates

false 0001812173 0001812173 2025-09-23 2025-09-23 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2025-09-23 2025-09-23 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2025-09-23 2025-09-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 23, 2025

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39384		87-2678169
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

78 Fourth Avenue
Waltham, Massachusetts		02451
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 868-1700

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common stock, par value $0.0001 per share		RBOT		The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share		RBOT WS		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

As of September 23, 2025, Vicarious Surgical Inc. (the “Company”) updated its investor presentation (the “Presentation”), which its senior management intends to use from time to time when interacting with investors and analysts, among others. The Presentation is available on the Company’s website at https://investor.vicarioussurgical.com/events-and-presentations/. A copy of the Presentation is also furnished hereto as Exhibit 99.1.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Investor Presentation
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICARIOUS SURGICAL INC.
	By:	/s/ Stephen From
	Name:	Stephen From
	Title:	Chief Executive Officer

Date: September 23, 2025

2